Home > Press > Oxonica’s CEO Appointed to the Elementis Board
Oxonica Ltd announces today that its chief executive, Dr. Kevin Matthews has been appointed to the Board of Elementis plc, as a non-executive director with effect from 16th February 2005.
Oxonica’s CEO Appointed as a Non-executive Director to the Elementis Board
February 17, 2005
Oxonica Limited is a leading European technology group, with products already launched into the global market.
The company was spun-out in 1999 from the University of Oxford and is based in Oxford, England. Oxonica currently employs 30 professional staff and is lead by a strong and commercially experienced management team.
Oxonica’s mission is to develop commercial solutions from nanotechnology. It owns a diverse portfolio of demand driven products that offer substantial benefits to the target markets of environmental, healthcare and materials.
Lead products include:
- Envirox™ Fuel Borne Catalyst – A nanocataylst optimising fuel economy and reducing emissions
- Optisol™ UV Filter – A range of ultra-stable UVA absorbers with enhanced free radical scavenging, with immediate applications in sunscreens and other cosmetics
Oxonica is also active in searching for the next generation of products and is already engaged in developing transformational detection technologies which will enable a new generation of diagnostic products for the clinical diagnostic and life science markets.
In addition, the company is developing other UV absorber technologies into polymer systems and coatings, based on similar technologies to that used in Optisol™.
01865 856 728
Island House, Forest Road, Guernsey, GY8 0AB, UK
Tel +44 (0) 1481 233080
Fax +44 (0) 1481 233082
Copyright © Oxonica
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Maximum Precision in 3D Printing: New complete solution makes additive manufacturing standard for microfabrication February 26th, 2015
Real-time observation of bond formation by using femtosecond X-ray liquidography February 26th, 2015
Bruker-Sponsored Sixth AFM BioMed Conference Highlights Increasing Impact of AFM in Biological Applications February 26th, 2015
Graphene shows potential as novel anti-cancer therapeutic strategy: University of Manchester scientists have used graphene to target and neutralise cancer stem cells while not harming other cells February 26th, 2015
KIT Increases Commitment in Asia: DAAD Funds Two New Projects: Strategic Partnerships with Chinese Universities and Communi-cation Technologies Network February 22nd, 2015
SouthWest Nanotechnologies CEO Dave Arthur Appointed to the Board of Affiliates of Rice University Professional Science Master’s Program February 13th, 2015
Nexeon Board Changes Announced January 29th, 2015
Rice's Naomi Halas to direct Smalley Institute: Optics pioneer will lead Rice's multidisciplinary science institute January 15th, 2015